Recombinant Anti-Human IGF-IR Antibody (Fc glycosylation) (CAT#: Gly-047LC)
This product is a human monoclonal antibody with N-glycosylation site Asn297 in the Fc region. The antibody with enhanced ADCC specifically binds human IGF-IR and can be potentially used in the treatment of diabete.
Specific Inquiry
Glyco-engineering
- Glycosylation site
- Asn297 in Fc region
- Glycoform (ratio)
- G0 (38.4%)
G1 (51.4%)
G2 (10.2%)
- Glycosylation Type
- N-glycosylation
- Activity
- Enhanced ADCC
Specifications
- Target
- IGF-IR (Insulin-like growth factor-binding protein)
- Host Species
- Human
- Type
- Human antibody
- Specificity
- Human
- Clone
- Clone 1
- Applications
- ELISA
Target
- Alternative Names
- IGF-IR; Insulin-like growth factor-binding protein
- Related Disease
- Diabete
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for Gly-047LC. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
Application: SPR, Inhib, FuncS
Application: WB, ELISA, IF, FuncS, Apop, BA
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
